Emotional crises negatively affect the clinical course and treatment in patients with borderline personality disorder (BPD), especially by increasing the number of psychiatric emergency consultations. B·RIGHT (Rapid Intervention Guidelines using Health Technology for Borderline personality) combines advanced artificial intelligence (AI) algorithms with a therapeutic app to help patients with their additional psychological needs when dealing with emotional crises.
- To provide satisfactory treatments during emotional crises for people with BPD or related personality traits, while making the most of the human and financial resources available in healthcare systems.
Problem to Solve
BPD is a severe mental disorder that causes emotional dysregulation and affects 2% of the adult population. Likewise, around 20% of the population also present personality traits that have a negative impact on their daily life. When these patients undergo an emotional crisis, they experience severe emotional dysregulation, suffering cognitive and behavioural changes that have a negative impact on their daily quality of life and their treatment (e.g., recurrent psychiatric emergency consultations).
Despite the fact that there are already empirically validated treatments that help optimise emotional dysregulation, the results are still far from ideal in terms of therapeutic range. Consequently, emotional crisis management is still a key aspect that needs to be solved during therapy for patients with BPD or related personality traits.
B·RIGHT is a treatment support app for people with BPD or related personality traits that makes innovative use of AI models. So far, B·RIGHT has a prototype app that you can see here (phase 1), and has received positive feedback from 25 patients (phase 2) who used it while self-managing an emotional crisis. The next phase will see a clinical trial involving 75 more patients and further fine-tuning of the AI algorithms.
Level of Innovation
B·RIGHT will be a clinical app prescribed by clinicians. The brand has already been registered in the United States, and the technology has also been approved by the European Union Intellectual Property Office.